pubmed-article:7908994 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7908994 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:7908994 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
pubmed-article:7908994 | lifeskim:mentions | umls-concept:C0069515 | lld:lifeskim |
pubmed-article:7908994 | lifeskim:mentions | umls-concept:C0086231 | lld:lifeskim |
pubmed-article:7908994 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:7908994 | lifeskim:mentions | umls-concept:C0392762 | lld:lifeskim |
pubmed-article:7908994 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:7908994 | pubmed:dateCreated | 1994-5-19 | lld:pubmed |
pubmed-article:7908994 | pubmed:abstractText | The introduction of c-erbB-2 protein to clinical medicine as a prognostic indicator and tumor marker is desired. The authors determined the concentration of c-erbB-2 protein in 81 breast cancer tissues by enzyme immunoassay. The concentration of c-erbB-2 protein in breast cancer tissues showed a broad spectrum. A significant correlation was observed between tissue c-erbB-2 protein concentration and estrogen receptor status or immunohistochemical determination. In patients with distant metastases, there was a close association between c-erbB-2 protein concentration in the primary tumor and serum c-erbB-2 protein level. Cases with a high tumor concentration of c-erbB-2 protein (> 1000 U/mg total protein; 18.5% of cases) had a poor prognosis. From the above, we concluded the measurement of tissue c-erbB-2 protein by enzyme immunoassay to be clinically useful in breast cancer. | lld:pubmed |
pubmed-article:7908994 | pubmed:language | eng | lld:pubmed |
pubmed-article:7908994 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7908994 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7908994 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7908994 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7908994 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7908994 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7908994 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7908994 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7908994 | pubmed:month | Apr | lld:pubmed |
pubmed-article:7908994 | pubmed:issn | 0368-2811 | lld:pubmed |
pubmed-article:7908994 | pubmed:author | pubmed-author:NaritaTT | lld:pubmed |
pubmed-article:7908994 | pubmed:author | pubmed-author:TakagiHH | lld:pubmed |
pubmed-article:7908994 | pubmed:author | pubmed-author:ImaiTT | lld:pubmed |
pubmed-article:7908994 | pubmed:author | pubmed-author:SatohYY | lld:pubmed |
pubmed-article:7908994 | pubmed:author | pubmed-author:FunahashiHH | lld:pubmed |
pubmed-article:7908994 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7908994 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:7908994 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7908994 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7908994 | pubmed:pagination | 74-8 | lld:pubmed |
pubmed-article:7908994 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:meshHeading | pubmed-meshheading:7908994-... | lld:pubmed |
pubmed-article:7908994 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7908994 | pubmed:articleTitle | Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay. | lld:pubmed |
pubmed-article:7908994 | pubmed:affiliation | Department of Surgery II, Nagoya University School of Medicine. | lld:pubmed |
pubmed-article:7908994 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7908994 | lld:pubmed |